U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C9H13NO3.ClH
Molecular Weight 219.665
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORMETANEPHRINE HYDROCHLORIDE, (±)-

SMILES

Cl.COC1=CC(=CC=C1O)C(O)CN

InChI

InChIKey=VKFPRGQZWKTEON-UHFFFAOYSA-N
InChI=1S/C9H13NO3.ClH/c1-13-9-4-6(8(12)5-10)2-3-7(9)11;/h2-4,8,11-12H,5,10H2,1H3;1H

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Measurement of urinary metanephrines to screen for pheochromocytoma in an unselected hospital referral population.
2006-11
The role of chromogranin A in the management of patients with phaeochromocytoma.
2006-09
Phaeochromocytoma in pregnancy.
2006-09
Cortisol production rate in posttraumatic stress disorder.
2006-09
Pretreatment and one-shot separating analysis of whole catecholamine metabolites in plasma by using LC/MS.
2006-07
A case of sleep apnea syndrome manifesting severe hypertension with high plasma norepinephrine levels.
2006-06
Absence of exercise-induced leptin suppression associated with insufficient epinephrine reserve in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
2006-03
[Diffuse uptake of brown fat on computed-tomography coupled positron emission tomoscintigraphy (PET-CT) for the exploration of extra-adrenal pheochromocytoma].
2006-03
Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.
2006-03
Low catechol-O-methyltransferase activity in the brain and blood pressure regulation.
2006-02
Paradoxical decrease in blood pressure after relief of cardiac tamponade: the role of sympathetic activity.
2006-02
Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
2006-01-11
Detecting pheochromocytoma: defining the most sensitive test.
2006-01
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery.
2006
Age-related differences in hormonal and nutritional impact on lean anorexia nervosa bone turnover uncoupling.
2006
[Metanephrine (M), normetanephrine (NM) and fractionated metanephrines].
2005-08
Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.
2005-08
Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction.
2005-06
Improved assay for catechol-O-methyltransferase activity utilizing norepinephrine as an enzymatic substrate and reversed-phase high-performance liquid chromatography with fluorescence detection.
2005-05-13
Rapid assay for catechol-O-methyltransferase activity by high-performance liquid chromatography-fluorescence detection.
2005-05-05
Training of elite cyclists: effects on mood state and selected hormonal responses.
2005-04-02
Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
2005-04
Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine.
2005-04
Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas.
2005-03-28
The use of plasma metanephrine to normetanephrine ratio to determine epinephrine poisoning.
2005-03
Expression of human dopamine receptor in potato (Solanum tuberosum) results in altered tuber carbon metabolism.
2005-02-09
Precisely wrong? Urinary fractionated metanephrines and peer-based laboratory proficiency testing.
2005-02
Plasma metanephrines in renal failure.
2005-02
Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.
2005-01
Pheochromocytoma presenting as heart failure.
2005
Decomposition of protonated noradrenaline and normetanephrine assisted by NH2 migration studied by electrospray tandem mass spectrometry and molecular orbital calculations.
2005
Nonparametric determination of reference intervals for plasma metanephrine and normetanephrine.
2004-12
Assessment of O-methylated catecholamine levels in plasma and urine for diagnosis of autonomic disorders.
2004-11-30
Laparoscopic adrenalectomy for isolated adrenal metastasis.
2004-11-24
Extraneuronal enzymatic degradation of myocardial interstitial norepinephrine in the ischemic region.
2004-10-01
Malignant pheochromocytoma associated with germline mutation of the SDHB gene.
2004-10
Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines.
2004-07
Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
2004-07
Predictive value of preoperative transthoracic echocardiography in patients undergoing adrenalectomy for pheochromocytoma.
2004-07
Experience with surgical excision in childhood pheochromocytoma.
2004-06
The economic implications of three biochemical screening algorithms for pheochromocytoma.
2004-06
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine.
2004-05
Toward a rapidly acting antidepressant: the normetanephrine and extraneuronal monoamine transporter (uptake 2) hypothesis.
2004-05
Diagnosis and localization of pheochromocytoma.
2004-05
Hormonal changes during long-term isolation.
2004-05
In vivo assessment of catechol O-methyltransferase activity in rabbit skeletal muscle.
2004-04-30
The catecholamine biosynthesis route in potato is affected by stress.
2004-04-16
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma.
2004-03
Laparoscopic management of extra-adrenal pheochromocytoma.
2004-01
Alterations of brain tissue in fetal rats exposed to nicotine in utero: possible involvement of nitric oxide and catecholamines.
2002-12-03
Patents

Patents

Name Type Language
DL-NORMETANEPHRINE HYDROCHLORIDE
MI  
Preferred Name English
NORMETANEPHRINE HYDROCHLORIDE, (±)-
Common Name English
NORMETANEPHRINE HYDROCHLORIDE
Common Name English
VANILLYL ALCOHOL, .ALPHA.-(AMINOMETHYL)-, HYDROCHLORIDE, (±)-
Common Name English
(±)-.ALPHA.-(AMINOMETHYL)-4-HYDROXY-3-METHOXYBENZYL ALCOHOL HYDROCHLORIDE
Systematic Name English
NORMETADRENALINE HYDROCHLORIDE
Common Name English
(±)-NORMETANEPHRINE HYDROCHLORIDE
Common Name English
BENZENEMETHANOL, .ALPHA.-(AMINOMETHYL)-4-HYDROXY-3-METHOXY-, HYDROCHLORIDE, (±)-
Systematic Name English
DL-NORMETANEPHRINE HYDROCHLORIDE [MI]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID40905944
Created by admin on Mon Mar 31 20:11:28 GMT 2025 , Edited by admin on Mon Mar 31 20:11:28 GMT 2025
PRIMARY
CAS
1011-74-1
Created by admin on Mon Mar 31 20:11:28 GMT 2025 , Edited by admin on Mon Mar 31 20:11:28 GMT 2025
PRIMARY
ECHA (EC/EINECS)
213-787-2
Created by admin on Mon Mar 31 20:11:28 GMT 2025 , Edited by admin on Mon Mar 31 20:11:28 GMT 2025
PRIMARY
FDA UNII
E2RS049K51
Created by admin on Mon Mar 31 20:11:28 GMT 2025 , Edited by admin on Mon Mar 31 20:11:28 GMT 2025
PRIMARY
PUBCHEM
102542
Created by admin on Mon Mar 31 20:11:28 GMT 2025 , Edited by admin on Mon Mar 31 20:11:28 GMT 2025
PRIMARY